CA964193A - Injectable compositions containing salts of l-tetramisole - Google Patents

Injectable compositions containing salts of l-tetramisole

Info

Publication number
CA964193A
CA964193A CA088,685A CA88685A CA964193A CA 964193 A CA964193 A CA 964193A CA 88685 A CA88685 A CA 88685A CA 964193 A CA964193 A CA 964193A
Authority
CA
Canada
Prior art keywords
tetramisole
compositions containing
injectable compositions
containing salts
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA088,685A
Other languages
English (en)
Other versions
CA88685S (en
Inventor
Bruce A. Forsyth
David E. Pryor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orica Ltd
Original Assignee
Imperial Chemical Industries of Australia and New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries of Australia and New Zealand Ltd filed Critical Imperial Chemical Industries of Australia and New Zealand Ltd
Application granted granted Critical
Publication of CA964193A publication Critical patent/CA964193A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA088,685A 1969-07-21 1970-07-21 Injectable compositions containing salts of l-tetramisole Expired CA964193A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU5831169 1969-07-21

Publications (1)

Publication Number Publication Date
CA964193A true CA964193A (en) 1975-03-11

Family

ID=3743604

Family Applications (1)

Application Number Title Priority Date Filing Date
CA088,685A Expired CA964193A (en) 1969-07-21 1970-07-21 Injectable compositions containing salts of l-tetramisole

Country Status (9)

Country Link
US (1) US3670086A (fr)
BE (1) BE753710A (fr)
CA (1) CA964193A (fr)
DE (1) DE2036114C3 (fr)
FR (1) FR2059541B1 (fr)
GB (1) GB1287673A (fr)
IE (1) IE34373B1 (fr)
NL (1) NL165653C (fr)
ZA (1) ZA704419B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096271A (en) * 1977-08-03 1978-06-20 American Cyanamid Company Slow release injectable formulations of tetramisole and derivatives in benzyl benzoate
AR045261A1 (es) 2003-08-12 2005-10-19 3M Innovative Properties Co Compuestos que contienen imidazo quinolina o imidazo piridina sustituidos; composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos inmunomoduladores
ES2406730T3 (es) 2003-08-27 2013-06-07 3M Innovative Properties Company Imidazoquinolinas sustituidas con ariloxi y arilalquilenoxi
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AR046046A1 (es) 2003-10-03 2005-11-23 3M Innovative Properties Co Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
US7897767B2 (en) 2003-11-14 2011-03-01 3M Innovative Properties Company Oxime substituted imidazoquinolines
CA2545825A1 (fr) 2003-11-14 2005-06-02 3M Innovative Properties Company Composes d'un anneau d'imidazo substitue par hydroxylamine
MXPA06005910A (es) 2003-11-25 2006-08-23 3M Innovative Properties Co Sistemas de anillo imidazo sustituido y metodos.
EP1701955A1 (fr) 2003-12-29 2006-09-20 3M Innovative Properties Company Imidazoquinolines a substitution arylalcenyle et arylalkynyle
WO2005066169A2 (fr) 2003-12-30 2005-07-21 3M Innovative Properties Company Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle
CA2559863A1 (fr) 2004-03-24 2005-10-13 3M Innovative Properties Company Imidazopyridines, imidazoquinolines, et imidazonaphthyridines a substitution amide
WO2005123080A2 (fr) 2004-06-15 2005-12-29 3M Innovative Properties Company Imidazoquinolines et imidazonaphthyridines substituees par un heterocyclyle contenant un azote
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006065280A2 (fr) 2004-06-18 2006-06-22 3M Innovative Properties Company Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009832A1 (fr) * 2004-06-18 2006-01-26 3M Innovative Properties Company Systemes cycliques imidazo substitues, et procedes correspondants
ES2392648T3 (es) 2004-12-30 2012-12-12 3M Innovative Properties Company Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
JP2008526757A (ja) * 2004-12-30 2008-07-24 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調節剤製剤および方法
CA2597092A1 (fr) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Formulations des gel aqueux contenant des modificateurs de reponse immunitaire
CA2597587A1 (fr) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes
JP2008538550A (ja) 2005-04-01 2008-10-30 コーリー ファーマシューティカル グループ，インコーポレイテッド ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての１−置換ピラゾロ（３，４−ｃ）環状化合物
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
WO2008008432A2 (fr) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants
CN104906036A (zh) * 2015-06-12 2015-09-16 重庆市畜牧科学院 阿魏酸左旋咪唑注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (fr) * 1964-05-11
AU421744B2 (en) * 1967-08-24 1972-02-24 I. C. I. Australia Limited Chemical process

Also Published As

Publication number Publication date
IE34373B1 (en) 1975-04-16
IE34373L (en) 1971-01-21
GB1287673A (en) 1972-09-06
NL165653B (nl) 1980-12-15
NL165653C (nl) 1981-05-15
NL7010558A (fr) 1971-01-25
DE2036114B2 (de) 1979-01-18
FR2059541A1 (fr) 1971-06-04
FR2059541B1 (fr) 1974-10-11
DE2036114A1 (de) 1971-02-04
US3670086A (en) 1972-06-13
BE753710A (fr) 1970-12-31
ZA704419B (en) 1971-04-28
DE2036114C3 (de) 1979-09-13

Similar Documents

Publication Publication Date Title
CA964193A (en) Injectable compositions containing salts of l-tetramisole
CA955390A (en) Compositions containing aminopolyureylene resin
ZM4370A1 (en) Novel compositions of matter
CA978538A (en) Phosphonate compositions
GB1324599A (en) Manufacture of rubber-bitumen compositions
CA927079A (en) Pressure-oxidation of metal-sulfur-containing compositions
IL34089A (en) Pharmaceutical compositions containing penicillin or cephalosphorin derivatives
CA923425A (en) Compositions containing garcinia acid
AU2085570A (en) Rubber-polyester compositions
CA979900A (en) Dialkyltin salts of substituted pyridine-1-oxides
AU4067468A (en) Compositions of matter
AU450313B2 (en) Injectable oxytetracycline compositions
AU4960269A (en) Composition of matter
AU453663B2 (en) Compositions containing n-dioctylethylene-triamines
AU437962B2 (en) Compositions of matter
CA777802A (en) Compositions of matter
AU456939B2 (en) Ester containing composition
AU1292270A (en) Improved beverage-forming compositions
AU453959B2 (en) Hydroxycitric acid derivatives containing compositions
AU449360B2 (en) Stabilizing composition
CA836563A (en) Composition of matter
CA796212A (en) Stabilized composition of quinonedihalimide compound
CA822730A (en) Compositions containing graphite
CA830476A (en) Therapeutic compositions containing aminocyclobutanols
AU1240870A (en) Injectable oxytetracycline compositions